EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 24 / No 12 (Décembre 2008) Med Sci (Paris), 24 12 (2008) 1055-1060 References
Free Access
Issue
Med Sci (Paris)
Volume 24, Number 12, Décembre 2008
Page(s) 1055 - 1060
Section M/S revues
DOI https://doi.org/10.1051/medsci/200824121055
Published online 15 December 2008
  1. Richman D D. HIV chemotherapy. Nature 2001; 410 : 995–1001. [Google Scholar]
  2. Perelson AS, Neumann AU, Markowitz M. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271 : 1582–6. [Google Scholar]
  3. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000; 18 : 665–708. [Google Scholar]
  4. Blankson, JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002; 53 : 557–93. [Google Scholar]
  5. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192 : 63–75. [Google Scholar]
  6. Estaquier J, Idziorek T, de Bels F, et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994; 91 : 9431–5. [Google Scholar]
  7. Estaquier J, Idziorek T, Zou W, et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182 : 1759–67. [Google Scholar]
  8. Mueller YM, De Rosa SC, Hutton JA, et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. Immunity 2001; 15 : 871–82. [Google Scholar]
  9. Hurtrel B, Petit F, Arnoult D, et al. Apoptosis in SIV infection. Cell Death Differ 205; 1 (suppl 12) : 979–90. [Google Scholar]
  10. Heise C, Vogel C, Miller CJ, et al. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol 1993; 142 : 1759–71. [Google Scholar]
  11. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280 : 427–31. [Google Scholar]
  12. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434 : 1093–7. [Google Scholar]
  13. Mehandru S, Poles PA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200 : 761–70. [Google Scholar]
  14. Cumont MC, Diop O, Vaslin B, et al. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol 2008; 82 : 1175–84. [Google Scholar]
  15. Monceaux V, Viollet L, Petit F, et al. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol 2007; 81 : 13865–75. [Google Scholar]
  16. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 1996; 18 : 441–52. [Google Scholar]
  17. Monceaux V, Ho R, Tsong Fang MC, et al. Distinct cycling CD4+- and CD8+-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques. J Virol 2003; 77 : 10047–73. [Google Scholar]
  18. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104 : 942–7. [Google Scholar]
  19. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 2004; 8 : 133–46. [Google Scholar]
  20. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113 : 685–700. [Google Scholar]
  21. Mempel TR, Pittet MJ, Khazaie K, et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006; 25 : 129–41. [Google Scholar]
  22. Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med 2001; 7 : 1118–27. [Google Scholar]
  23. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996; 110 : 975–84. [Google Scholar]
  24. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182:190–200. [Google Scholar]
  25. MacPherson G, Milling S, Yrlid U, et al. Uptake of antigens from the intestine by dendritic cells. Ann NY Acad Sci 2004; 1029 : 75–82. [Google Scholar]
  26. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4 : 762–74. [Google Scholar]
  27. Estes JD, Li Q, Reynolds MR, et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006; 193 : 703–12. [Google Scholar]
  28. Hryniewicz A, Boasso A, Edghill-Smith Y, et al. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006; 108 : 3834–42. [Google Scholar]
  29. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002; 9 : 1069–77. [Google Scholar]
  30. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443 : 350–4. [Google Scholar]
  31. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12 : 1198–202. [Google Scholar]
  32. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203 : 2281–92. [Google Scholar]
  33. Velu V, Kannanganat S, Ibegbu C, et al. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol 2007; 81 : 5819–21. [Google Scholar]
  34. Petrovas C, Price DA, Mattapallil J, et al. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 2007; 110 : 928–36. [Google Scholar]
  35. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11 : 3887–94. [Google Scholar]
  36. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25 : 9543–53. [Google Scholar]
  37. Schleifer K, Mansfield JM. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 1993; 151 : 5492–503. [Google Scholar]
  38. Terabe M, Matsui S, Park JM, et al. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 2003; 198 : 1741–52. [Google Scholar]
  39. Cumont MC, Monceaux V, Viollet L, et al. TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhésus macaques infected with the simian immunodeficiency virus. Cell Death Differ 2007; 14 : 1747–58. [Google Scholar]
  40. Lévy Y. Immunothérapie de l’infection par le VIH par l’utilisation de cytokines : un état des lieux. Med Sci (Paris) 2006; 22 : 751–4. [Google Scholar]
  41. Courgnaud V, Müller-Trutwin M, Sonigo P. Évolution et virulence des lentivirus de primates. Med Sci (Paris) 2004; 20 : 448–52. [Google Scholar]
  42. Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9. [Google Scholar]
  43. Trautmann L, Chomont N, Sékaly RP. L’inhibition de la voie PD-1 permet de restaurer les fonctions effectrices des lymphocytes spécifiques du VIH. Med Sci (Paris) 2007; 23 : 24–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.